Home » Stocks » STAAR Surgical

STAAR Surgical Company (STAA)

Stock Price: $46.99 USD -0.68 (-1.43%)
Updated Aug 14, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 2.15B
Revenue (ttm) 148.32M
Net Income (ttm) 7.46M
Shares Out 45.81M
EPS (ttm) 0.16
PE Ratio 293.69
Forward PE 222.22
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 14, 2020
Last Price $46.99
Previous Close $47.67
Change ($) -0.68
Change (%) -1.43%
Day's Open 47.39
Day's Range 46.01 - 47.75
Day's Volume 653,834
52-Week Range 23.20 - 62.51

More Stats

Market Cap 2.15B
Enterprise Value 2.04B
Earnings Date (est) Oct 28, 2020
Ex-Dividend Date n/a
Shares Outstanding 45.81M
Float 31.22M
EPS (basic) 0.17
EPS (diluted) 0.16
FCF / Share 0.08
Dividend n/a
Dividend Yield n/a
Earnings Yield 0.34%
FCF Yield 0.17%
Payout Ratio n/a
Shares Short 3.02M
Short Ratio 4.69
Short % of Float 8.38%
Beta 1.61
PE Ratio 293.69
Forward PE 222.22
P/FCF Ratio 582.53
PS Ratio 14.51
PB Ratio 14.65
Revenue 148.32M
Operating Income 3.49M
Net Income 7.46M
Free Cash Flow 3.70M
Net Cash 108.71M
Net Cash / Share 2.37
Gross Margin 75.48%
Operating Margin 2.35%
Profit Margin 5.00%
FCF Margin 2.49%
ROA 1.05%
ROE 4.68%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (7)

Buy 5
Overweight 0
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(37.48% upside)
Current: $46.99
Target: 64.60
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth21.16%36.8%9.92%6.88%2.85%3.84%13.22%1.62%14.21%-
Gross Profit11291.5164.2858.3752.7248.8250.3144.2942.3735.08
Operating Income11.856.60-3.63-12.66-5.34-8.030.70-1.222.78-2.60
Net Income14.054.97-2.14-12.13-6.53-8.390.40-1.761.350.05
Shares Outstanding44.4942.5941.0040.3339.2638.0936.7136.2535.4334.83
Earnings Per Share0.300.11-0.05-0.30-0.17-0.220.01-0.050.04-
EPS Growth172.73%---------
Operating Cash Flow25.8012.772.851.05-2.16-7.953.363.225.35-4.42
Capital Expenditures-10.10-2.25-1.05-3.21-2.04-4.05-3.45-2.27-0.94-0.29
Free Cash Flow15.7010.521.81-2.16-4.21-12.01-0.090.954.41-4.71
Cash & Equivalents12010418.5214.0013.4013.0122.9521.6816.719.51
Total Debt9.545.346.256.824.735.
Net Cash / Debt11098.5412.277.188.688.0017.7814.5112.416.62
Book Value16013242.9437.9138.8537.1038.8531.7429.4622.43
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name STAAR Surgical Company
Country United States
Employees 550
CEO Caren L. Mason

Stock Information

Ticker Symbol STAA
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: STAA


STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells its products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in China, Korea, India, and internationally. STAAR Surgical Company was founded in 1982 and is based in Monrovia, California.